67.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$66.10
Aprire:
$67.08
Volume 24 ore:
2.75M
Relative Volume:
1.56
Capitalizzazione di mercato:
$8.19B
Reddito:
$12.50B
Utile/perdita netta:
$314.00M
Rapporto P/E:
27.66
EPS:
2.44
Flusso di cassa netto:
$421.00M
1 W Prestazione:
+4.12%
1M Prestazione:
-8.06%
6M Prestazione:
-12.56%
1 anno Prestazione:
-0.57%
Henry Schein Inc Stock (HSIC) Company Profile
Nome
Henry Schein Inc
Settore
Industria
Telefono
(631) 843-5500
Indirizzo
135 DURYEA RD, MELVILLE, NY
Confronta HSIC con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
HSIC
Henry Schein Inc
|
67.50 | 8.02B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
MCK
Mckesson Corporation
|
659.01 | 83.68B | 377.60B | 3.16B | 5.67B | 25.08 |
![]()
COR
Cencora Inc
|
289.15 | 56.36B | 316.65B | 1.90B | 1.14B | 9.72 |
![]()
CAH
Cardinal Health Inc
|
146.30 | 37.63B | 222.29B | 1.56B | 2.44B | 6.41 |
![]()
AHG
Akso Health Group Adr
|
1.86 | 689.96M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-25 | Downgrade | Stifel | Buy → Hold |
2025-07-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
2025-01-06 | Aggiornamento | BofA Securities | Underperform → Buy |
2024-12-04 | Iniziato | Mizuho | Neutral |
2024-07-22 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2024-02-26 | Iniziato | Leerink Partners | Market Perform |
2023-12-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
2023-11-10 | Aggiornamento | Stifel | Hold → Buy |
2022-08-08 | Aggiornamento | UBS | Sell → Neutral |
2022-07-21 | Downgrade | Goldman | Buy → Neutral |
2022-06-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
2022-05-13 | Ripresa | Credit Suisse | Outperform |
2022-01-31 | Iniziato | Morgan Stanley | Underweight |
2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2021-10-01 | Ripresa | Credit Suisse | Neutral |
2021-02-08 | Ripresa | Piper Sandler | Overweight |
2021-01-04 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2020-11-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2020-04-07 | Aggiornamento | Goldman | Neutral → Buy |
2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2020-01-09 | Downgrade | BofA/Merrill | Neutral → Underperform |
2020-01-02 | Aggiornamento | Evercore ISI | Underperform → In-line |
2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
2019-05-30 | Iniziato | Wolfe Research | Underperform |
2019-05-15 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2019-04-18 | Iniziato | Guggenheim | Buy |
2019-01-17 | Iniziato | UBS | Sell |
2019-01-03 | Downgrade | Evercore ISI | In-line → Underperform |
2019-01-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
2018-11-08 | Reiterato | Barrington Research | Outperform |
2018-10-25 | Downgrade | Edward Jones | Hold → Sell |
2018-10-19 | Ripresa | Goldman | Neutral |
2018-10-04 | Reiterato | Robert W. Baird | Outperform |
2018-08-07 | Reiterato | Stifel | Hold |
2018-04-24 | Downgrade | Goldman | Buy → Neutral |
2018-04-04 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
Mostra tutto
Henry Schein Inc Borsa (HSIC) Ultime notizie
Stock Analysis | Henry Schein OutlookMixed Signals as Analysts and Fund Flows Diverge - AInvest
Oral Genome Partners with Henry Schein Nationwide - Dentistry Today
Is Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Price Struggling As A Result Of Its Mixed Financials? - 富途牛牛
Henry Schein (HSIC) Q2 EPS Drops 11% - AOL.com
Henry Schein, Inc. Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next - simplywall.st
Earnings Miss: Henry Schein, Inc. Missed EPS By 24% And Analysts Are Revising Their Forecasts - Yahoo Finance
Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top - MSN
Henry Schein maintains 2025 EPS guidance and targets over $100M in annual cost savings as CEO transition begins - MSN
Henry Schein (HSIC): Barrington Research Lowers Price Target | H - GuruFocus
Research Alert: CFRA Maintains Hold View On Shares Of Henry Schein, Inc. - 富途牛牛
Henry Schein 2025 Q2 Earnings Misses Targets, EPS Declines 12.3% - AInvest
Henry Schein Introduces ACCLEAN Cordless Hygiene Handpiece - Orthodontic Products
Henry Schein Reports Second Quarter 2025 Financial Results - Zenopa
Henry Schein Unveils New Cordless Hygiene Handpiece - Dentistry Today
Henry Schein, Inc. (NASDAQ:HSIC) Q2 2025 Earnings Call Transcript - Insider Monkey
Henry Schein Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Evercore ISI Adjusts Price Target on Henry Schein to $70 From $78, Maintains In Line Rating - MarketScreener
Mizuho Adjusts Price Target on Henry Schein to $74 From $76, Maintains Neutral Rating - MarketScreener
Henry Schein Inc (HSIC) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Market Challenges By GuruFocus - Investing.com Canada
Decoding Henry Schein Inc (HSIC): A Strategic SWOT Insight - GuruFocus
Henry Schein Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Henry Schein: Q2 Earnings Snapshot - Chron
Henry Schein's 2025 Outlook Hinges On Strong Second-Half Execution - AOL.com
Henry Schein falls after missing quarterly profit estimates - whbl.com
Henry Schein Q2 Earnings Miss Estimates, Revenue Grows 3.3% - AInvest
Henry Schein Q2 2025 slides: sales growth continues despite margin pressure - Investing.com
Why Henry Schein (HSIC) Shares Are Falling Today - Yahoo Finance
Henry Schein (HSIC) Q2 EPS Drops 11% - The Motley Fool
Earnings call transcript: Henry Schein Q2 2025 misses EPS, stock drops - Investing.com
Henry Schein's Q2 2025 Earnings Call: Contradictions in Tariff Impact, Market Stability, and Growth Potential - AInvest
Why Is Henry Schein Stock Falling Tuesday?Henry Schein (NASDAQ:HSIC) - Benzinga
Transcript : Henry Schein, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener
Henry Schein Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Henry Schein (HSIC) Q2 Earnings Lag Estimates - sharewise.com
Henry Schein Faces Pressure As US Dental Demand Slips - Finimize
Henry Schein reports second quarter 2025 financial results - MarketScreener
Henry Schein Q2 Earnings Fall Short, Revenue Exceeds ExpectationsNews and Statistics - IndexBox
Henry Schein Inc. Q2 Profit Decreases, Misses Estimates - Nasdaq
Henry Schein, Inc. Reaffirms Earnings Guidance for the Year 2025 - MarketScreener
Henry Schein Inc Q2 2025 Earnings: Non-GAAP EPS of $1.10 Beats E - GuruFocus
Henry Schein’s (NASDAQ:HSIC) Q2 Earnings Results: Revenue In Line With Expectations - Yahoo Finance
Henry Schein Fiscal Q2 Non-GAAP Earnings Fall, Revenue Rises; Maintains Fiscal 2025 Guidance - MarketScreener
Henry Schein's Q2 2025 Earnings: A Strategic Turnaround for Long-Term Value Creation Amid Margin Pressures - AInvest
Henry Schein earnings missed by $0.09, revenue fell short of estimates - Investing.com Canada
Earnings Flash (HSIC) Henry Schein, Inc. Reports Q2 Revenue $3.24B, vs. FactSet Est of $3.22B - MarketScreener
Earnings Flash (HSIC) Henry Schein, Inc. Posts Q2 Adjusted EPS $1.10 per Share, vs. FactSet Est of $1.19 - MarketScreener
Press Release: Henry Schein Reports Second Quarter 2025 Financial Results - 富途牛牛
Henry Schein Inc Azioni (HSIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):